Sandvik: Interim report second quarter 2009.
STOCKHOLM, Sweden -- Regulatory News:
* Order intake SEK 16,503 M * Invoiced sales SEK 18,011 M * Non-recurring costs of SEK 1,400 M * Operating profit SEK -1,985 M * Profit after financial items SEK -2,443 M * Earnings per share SEK -1.70 * Cash flow SEK +2,890 M
Accounting policies This interim report was prepared in accordance with IFRS, applying IAS 34, Interim Financial Reporting. The same accounting and valuation policies were applied as in the most recent annual report, with the exception of certain new standards and interpretations, which are applied from 1 January 2009.
Revised IAS 1 Presentation of financial statements entails that items recognized directly in equity that do not affect transactions with owners must now be recognized in the income statement under the heading Other comprehensive income. Sandvik has chosen to present other comprehensive income as a component in the income statement and not as a separate statement. The statement of changes in equity presents the total comprehensive income for the period and transactions with owners. The corresponding reclassifications have been made in the comparative figures.
In addition to the amendments in IAS 1, new standards and interpretations have not entailed any significant effects on Sandvik's financial reports. IFRS 8 Operating segments has not entailed any change to Sandvik's definition of the Group's segments.
The company's auditors have not conducted a special review of the Q2 2009 report. The Sandvik Group's interim report for the third quarter of 2008 will be published on 30 October 2009.
A combined presentation and teleconference will be held on 17 July 2009 at 13.30 CET at Operaterassen in Stockholm. Information available at www.sandvik.com/ir.
Sandviken den 17 July 2009
Sandvik Aktiebolag (publ)
Lars Pettersson President and CEO
Sandvik discloses the information provided herein pursuant to the Securities Market Act and/or the Financial Instruments Trading Act. The information is submitted for publication on 17 July at 08:00 CET.
This information was brought to you by Cision http://www.cisionwire.com
|Printer friendly Cite/link Email Feedback|
|Date:||Jul 17, 2009|
|Previous Article:||Meda: Onsolis receives FDA approval.|
|Next Article:||Saab Wins Australian Prison Security Contract.|
|Parker, Sandvik announce partnership.|
|Sandvik invests in future with center of excellence.|